Evogene Ltd. EVGN
0.27 USD -0.05 (-15.73%)
At closeNov 9, 2026, 4:20 AM EST
0.27 0.00 +0.18%
Pre-market · Nov 9, 4:20 AM ET
0.2503 Day range 0.28195
0.25 52-week range 1.28
- YTD
- -75.36%
- 1 year
- -76.64%
News
prnewswire.com Evogene Schedules Third Quarter 2026 Financial Results Release Zoom conference call scheduled for November 19, 2026, 9:00 AM ET REHOVOT, Israel, Nov. 5, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational…
benzinga.com Evogene Announces Acute Graft-Versus-Host Disease As Target Indication For Its Internal Drug Discovery Program Advancing a First-in-Class Small-Molecule Therapeutic, Guided by World-Leading Experts, to Address a Multi-Billion-Dollar Unmet Need in Steroid-Refractory PatientsREHOVOT, Israel, Oct. 28, 2026…